Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.530
-0.050 (-1.40%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Alvotech Revenue
In the year 2025, Alvotech had annual revenue of $588.90M with 19.70% growth. Alvotech had revenue of $168.90M in the quarter ending December 31, 2025, with 10.14% growth.
Revenue (ttm)
$588.90M
Revenue Growth
+19.70%
P/S Ratio
1.88
Revenue / Employee
$581,921
Employees
1,012
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 588.90M | 96.93M | 19.70% |
| Dec 31, 2024 | 491.98M | 398.60M | 426.84% |
| Dec 31, 2023 | 93.38M | 8.37M | 9.84% |
| Dec 31, 2022 | 85.02M | 45.33M | 114.23% |
| Dec 31, 2021 | 39.68M | -29.77M | -42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Evotec SE | 887.40M |
| ANI Pharmaceuticals | 883.37M |
| Tilray Brands | 837.32M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Amphastar Pharmaceuticals | 719.89M |
| Harrow | 272.30M |
ALVO News
- 2 days ago - Alvotech Q4 2025 and Full Year 2025 Financial Results - GlobeNewsWire
- 17 days ago - Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Alvotech Announces Increase in Number of Own Shares - GlobeNewsWire
- 6 weeks ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire
- 6 weeks ago - Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - GlobeNewsWire
- 2 months ago - Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 2 months ago - Correction: Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 2 months ago - Transactions of Managers and Closely Associated Persons - GlobeNewsWire